Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis
NCT03720340
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG:
Recombinant Human Interleukin-11
DRUG:
Saline
Sponsor
Zhejiang Cancer Hospital